SBS88 - AN OVERVIEW

We mixed the data from regular and neoplastic samples from our cancer individuals with a new dataset from regular crypts of healthy patients9, and carried out mutational signature discovery applying SparseSignature20, a way that avoids overfitting of signatures by implementing sparsity on the sign (Supplementary Fig. three). We obtained signatures